Molecular imaging holds the promise for improved patient management in medicine and surgery. To realize this goal, a thorough understanding of the instrumentation and diagnostic agents that comprise the field is necessary, as is an understanding of why the field has yet to live up to its potential. Advanced Molecular Imaging and its Clinical Translation will provide a comprehensive educational experience in the physics, chemistry, engineering, and physiology that are the foundation of molecular imaging. It will also include key leaders from industry, who will bring their perspective on how intellectual property, regulatory approval, and reimbursement impact patient care. Faculty from around the world specializing in basic science, clinical translation, and clinical applications have been carefully chosen to bring course attendees to the state-of-the-art in the field.
The course is designed to encourage interactive audience participation with frequent question and answer sessions, and breaks, with the faculty and other attendees.
The course will cover most aspects of molecular imaging including optical imaging, SPECT, PET, CT, MRI, ultrasound, combinations thereof, contrast agent chemistry, radiotracer development, preclinical imaging, regulatory, statistical, reimbursement, and logistical issues surrounding clinical translation, and state-of-the-art clinical imaging in cancer, heart disease, neurology, and other human conditions. Distinguished guest faculty from around the world, including members of the faculty of the Harvard Medical School, will update physicians, scientists, and trainees on the latest techniques in molecular imaging as well as those under development and slated for clinical implementation in the future. Faculty will also offer a glimpse into emerging methodologies in molecular imaging that could become part of clinical practice within the next decade.
Please note that because of the purposeful interaction of academia and industry, this is NOT a continuing medical education (CME) course. NO CME CREDIT IS AVAILABLE.
This is the second annual iteration of the course. The first, titled Molecular Imaging: Preclinical and Clinical Advances, drew participants from around the world, suggesting that partnering with the World Molecular Imaging Society (WMIS) would be beneficial. We have also partnered with the FLARE Foundation, a nonprofit organization focused on worldwide medical technology dissemination. Based on feedback from the initial course, lectures have been shortened to permit more time for questions and answers, and industry has been engaged to address the present conundrum that most new technology in molecular imaging never becomes available for patient care.
John V. Frangioni, M.D., Ph.D.: Professor of Medicine and Professor of Radiology; Director, Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, MA.
Ralph Weissleder, M.D., Ph.D.: Professor of Radiology and Systems Biology; Massachusetts General Hospital, Boston, MA.